Suven Pharmaceuticals Ltd Quarterly Results

Gross Sales

307.15

257.72

230.69

252.93

219.82

Excise Duty

0

0

0

0

0

Net Sales

307.15

257.72

230.69

252.93

219.82

Other Operating Income

0

0

0

0

0

Other Income

15.71

14.12

18.16

17.05

14.34

Total Income

322.86

271.84

248.85

269.98

234.16

Total Expenditure

189.45

153.71

150.76

179.59

153.74

PBIDT

133.41

118.13

98.09

90.4

80.42

Interest

3.33

1.67

1.6

2.3

2.16

PBDT

130.08

116.46

96.49

88.1

78.26

Depreciation

20.35

16.96

13.4

17.25

12.79

Minority Interest Before NP

0

0

0

0

0

Tax

41.6

27.91

20.02

18.55

14.65

Deferred Tax

-15.16

-10.39

2.3

-1.07

4.07

Reported Profit After Tax

83.29

81.98

60.77

53.37

46.75

Minority Interest After NP

0.41

-0.23

0

0

0

Net Profit after Minority Interest

82.88

82.21

60.77

53.37

46.75

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

82.88

82.21

60.77

53.37

46.75

EPS (Unit Curr.)

3.26

3.23

2.39

2.1

1.84

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

25.46

25.46

25.46

25.46

25.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

43.43

45.83

42.52

35.74

36.58

PBDTM(%)

42.35

45.18

41.82

34.83

35.6

PATM(%)

27.11

31.8

26.34

21.1

21.26